DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mitozolomide
Mitozolomide
WO 2013/134349 Al 12 September 2013 (12.09.2013) P O P C T
Effect of Lonidamine on Systemic Therapy of DB-1 Human Melanoma Xenografts with Temozolomide KAVINDRA NATH 1, DAVID S
Activity of Mitozolomide (NSC 353451), a New Imidazotetrazine, Against Xenografts from Human Melanomas, Sarcomas, and Lung and Colon Carcinomas
Tanibirumab (CUI C3490677) Add to Cart
The Role of Receptor Tyrosine Kinases in Mediating Glioblastoma Resistance to Radiotherapy and Temozolomide
Autophagy As a Potential Therapy for Malignant Glioma
Stembook 2018.Pdf
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
FIGURE 1 Human Subjects with Bispecific Anti-CD 123 X Anti-CD3 Antibodies
Making the Most of Rodent Tumour Systems in Cancer Drug Discovery
(12) Patent Application Publication (10) Pub. No.: US 2014/0200250 A1 Peng Et Al
Drug Metabolism Group
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) Patent Application Publication (10) Pub. No.: US 2016/0220537 A1 GARNER Et Al
Treatment of Malignant Pheochromocytoma and Paraganglioma
Bidirectional Interplay of Nutrition and Chemotherapy
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Temozolomide and Treatment of Malignant Glioma1
Top View
Enhancing Hemopoietic Drug Resistance: a Rationale for Reconsidering the Clinical Use of Mitozolomide
Tesi Finale Lodicoalessia
Pharmaabkommen A1 E
The Medicinal Chemistry of Imidazotetrazine Prodrugs
Microtubule-Actin Crosslinking Factor 1 and Plakins As Therapeutic Drug Targets
Drugs Against Cancer: Stories of Discovery and the Quest for a Cure
The University of Hull Novel Anti-Endothelial
Customs Tariff - Schedule Xxi - 1
The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment
(12) Patent Application Publication (10) Pub. No.: US 2015/0151001 A1 Squires (43) Pub
Newperspectivesinlungcancer S5 New Drugs in Lung Cancer
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
A Novel Temozolomide–Perillyl Alcohol Conjugate Exhibits Superior Activity Against Breast Cancer Cells in Vitro and Intracranial Triple-Negative Tumor Growth in Vivo
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
( 12 ) United States Patent
Recent Patents on Live Bacteria and Their Products As Potential Anti- Cancer Agents
Mitozolomide Activity on Human Cancer Cells in Vitro E
Novel Approaches to Reduce Temozolomide Resistance in Glioblastoma Multiforme: a Review of the Literature
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
Carmustine Implants and Temozolomide for the Treatment of Newly Diagnosed High-Grade Glioma Vol
List Item Temozolomide Sandoz
Experimental Antitumor Activity Against Murine Tumor Model
2U11/135459 A2
Tumor Acidosis in Malignant Progression and Therapy
Modulation of Human Lymphocyte 06-Alkylguanine-DNA Alkyitransferase by Streptozotocin in Vivo1
Professor Tom Connors and the Development of Novel Cancer Therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Rapid Growth of Human Cancer Cells in a Mouse Model with Fibrin Clot Subrenal Capsule Assay1
Antineoplastic Drugs